Search Results 171-180 of 16682 for primary sclerosing cholangitis
Primary biliary cholangitis; Primary sclerosing cholangitis; Secondary sclerosing cholangitis. Diseases occurring after liver transplantation. Acute or ...
Doing clinical trials for new targeted therapies, which is possible because of Mayo Clinic's high patient volume for primary sclerosing cholangitis and bile ...
The purpose of this study is to assess the safety, tolerability and effectiveness of LJN452 for the treatment of patients who have primary biliary cholangitis.
Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid.
When Bruce Schwartau was diagnosed with primary sclerosing cholangitis, a chronic liver disease, he understood he'd eventually need a liver transplant.
The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ...
Primary sclerosing cholangitis. In this uncommon condition seen in people with IBD , inflammation causes scarring within the bile ducts. This scarring ...
Liver cancers, such as hepatocellular cancer and bile duct cancer (cholangiocarcinoma); Biliary tract diseases, such as primary sclerosing cholangitis and ...
Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma. Cancers (Basel). 2022 Apr 24; 14 (9)
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.